Partnership to advance protein sciences in drug discovery
ELRIG UK has partnered with The Protein Society (TPS) to provide forums for the advancement of research into protein structure, function, design and applications.
The partners will collaborate to deliver a joint conference on ‘Protein Sciences in Drug Discovery’, bringing together their respective communities to focus on the application of emerging areas of protein science to the challenges of drug discovery.
Working together will enable the organisations to create a productive interdisciplinary forum that incorporates diverse research interests and experimental approaches, offering their drug discovery and protein science communities the opportunity to connect and share ideas.
Protein Sciences in Drug Discovery 2024 takes place from 18–19 November at Hinxton Hall Conference Centre in Cambridge, UK.
The interactive event will bring together scientists from academia, pharma, biotech and CROs to discuss high-throughput methods for protein expression, approaches for generation of antigens for antibody and vaccine discovery, analytical techniques to interrogate protein quality, and the application of cryogenic electron microscopy (cryo-EM) for druggability, as well as sequence-based predictive methods.
The free-to-attend conference also includes poster presentations, networking sessions as well as a vendor exhibition, and offers travel bursary opportunities for early career professionals.
Melanie Leveridge, Vice President Discovery Biology at AstraZeneca and Chair of ELRIG UK, said: “Our organisations share a unifying goal — to provide a platform that enables academia and industry to exchange knowledge that supports innovation and fosters collaboration across the life science community.”
Professor Elizabeth Meiering, President of The Protein Society, and Professor at University of Waterloo, said: “Bringing together leading experts from complementary disciplines provides an exceptional opportunity to communicate the latest advances and techniques in protein science and how to apply them to support drug discovery.”